SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 8th, 2015 • Pozen Inc /Nc • Pharmaceutical preparations • New York
Contract Type FiledDecember 8th, 2015 Company Industry JurisdictionThis SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of December 7, 2015, by and among Aralez Pharmaceuticals Inc., a corporation formed under the laws of the Province of British Columbia, Canada (the “Company”), and those lenders set forth on Schedule 1 to the Amended Facility Agreement (as defined below) (each individually, a “Lender” and together, the “Lenders”).
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 30th, 2015 • Pozen Inc /Nc • Pharmaceutical preparations • New York
Contract Type FiledOctober 30th, 2015 Company Industry JurisdictionThis AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 29, 2015, by and among Aralez Pharmaceuticals Limited, a private limited company incorporated in Ireland with company registration number 561617 (formerly known as Aguono Limited) (the “Company”), and those lenders set forth on Schedule 1 to the Amended Facility Agreement (as defined below) (each individually, a “Lender” and together, the “Lenders”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 19th, 2014 • Alphatec Holdings, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 19th, 2014 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 17, 2014, by and among Alphatec Holdings, Inc., a Delaware corporation (the “Company”), and those lenders set forth on Schedule 1 to the Facility Agreement (as defined below) (each individually, a “Lender” and together, the “Lenders”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 25th, 2014 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2014 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of February 24, 2014 by and among Infinity Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and those lenders set forth on Schedule 1 to the Facility Agreement (as defined below) (each individually, a “Lender” and together, the “Lenders”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 22nd, 2014 • Exelixis, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledJanuary 22nd, 2014 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of January 22, 2014, by and between EXELIXIS, INC., a Delaware corporation (the “Company”), and Deerfield Partners, L.P., Delaware limited partnership, and Deerfield International Master Fund, L.P., a limited partnership organized under the laws of the British Virgin Islands (individually, a “Lender” and together, the “Lenders”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 19th, 2013 • IMRIS Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledSeptember 19th, 2013 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 16, 2013, by and among IMRIS Inc., a corporation incorporated under the Canada Business Corporations Act (the “Company”), and those lenders set forth on Schedule 1 to the Facility Agreement (as defined below) (each individually, a “Lender” and together, the “Lenders”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 15th, 2013 • Discovery Laboratories Inc /De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 15th, 2013 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of February 13, 2013, by and among Discovery Laboratories, Inc., a Delaware corporation (the “Company”), and those lenders set forth on Schedule 1 to the Facility Agreement (as defined below) (each individually, a “Lender” and together, the “Lenders”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 7th, 2012 • MAKO Surgical Corp. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledMay 7th, 2012 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May 7, 2012, by and among MAKO Surgical Corp., a Delaware corporation (the “Company”), and those lenders set forth on Schedule 1 to the Facility Agreement (as defined below) (each individually, a “Lender” and together, the “Lenders”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 18th, 2011 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 18th, 2011 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 15, 2011, by and among TITAN PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and those lenders set forth on Schedule 1 to the Facility Agreement (as defined below) (each individually, a “Lender” and together, the “Lenders”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 8th, 2010 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 8th, 2010 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 2, 2010, by and among ARENA PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and DEERFIELD PRIVATE DESIGN FUND, L.P., DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P., DEERFIELD PARTNERS, L.P., DEERFIELD INTERNATIONAL LIMITED, DEERFIELD SPECIAL SITUATIONS FUND, L.P. AND DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITED (as defined below) (each individually, a “Purchaser” and together, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 30th, 2008 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 30th, 2008 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 26, 2008, by and between ISTA PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and those lenders set forth on Schedule 1 to the Facility Agreement (as defined below) (individually a “Lender” and together, the “Lenders”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 9th, 2008 • Exelixis Inc • Services-commercial physical & biological research • New York
Contract Type FiledJune 9th, 2008 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 4, 2008, by and between EXELIXIS, INC., a Delaware corporation (the “Company”), and Deerfield Private Design Fund, L.P., a Delaware limited partnership, Deerfield Private Design International, L.P., a limited partnership organized under the laws of the British Virgin Islands, Deerfield Partners, L.P., Delaware limited partnership, and Deerfield International Limited, a corporation organized under the laws of the British Virgin Islands (individually, a “Lender” and together, the “Lenders”).